HK51197A - Platelet blocking peptides - Google Patents

Platelet blocking peptides

Info

Publication number
HK51197A
HK51197A HK51197A HK51197A HK51197A HK 51197 A HK51197 A HK 51197A HK 51197 A HK51197 A HK 51197A HK 51197 A HK51197 A HK 51197A HK 51197 A HK51197 A HK 51197A
Authority
HK
Hong Kong
Prior art keywords
blocking peptides
platelet
oligopeptides
platelet blocking
fibrinogen
Prior art date
Application number
HK51197A
Inventor
Israel F Charo
Laurence A Fitzgerald
David R Phillips
Original Assignee
Cor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapeutics Inc filed Critical Cor Therapeutics Inc
Publication of HK51197A publication Critical patent/HK51197A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Abstract

The present invention provides oligopeptides corresponding to regions of the GPIIIa protein, which are capable of specifically binding aggregation mediators, such as fibrinogen. The oligopeptides will typically comprise at least about 5 to 20 amino acids, and are thus non-immunogenic and easy to produce, formulate and administer.
HK51197A 1988-06-30 1997-04-17 Platelet blocking peptides HK51197A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21364188A 1988-06-30 1988-06-30
US33696289A 1989-04-12 1989-04-12

Publications (1)

Publication Number Publication Date
HK51197A true HK51197A (en) 1997-04-25

Family

ID=26908261

Family Applications (1)

Application Number Title Priority Date Filing Date
HK51197A HK51197A (en) 1988-06-30 1997-04-17 Platelet blocking peptides

Country Status (7)

Country Link
US (1) US5705606A (en)
EP (1) EP0422125B1 (en)
JP (1) JP2892726B2 (en)
AT (1) ATE144535T1 (en)
DE (1) DE68927379T2 (en)
HK (1) HK51197A (en)
WO (1) WO1990000178A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU639409B2 (en) * 1987-12-10 1993-07-29 La Jolla Cancer Research Foundation Conformationally stabilized cell adhesion peptides
US5827821A (en) * 1987-12-10 1998-10-27 The Burnham Institute Conformationally stabilized cell adhesion peptides
US5851839A (en) * 1989-06-16 1998-12-22 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5648330A (en) * 1990-04-06 1997-07-15 La Jolla Cancer Research Foundation Method and composition for treating vascular graft occlusion
DK0527798T3 (en) * 1990-04-06 1997-12-15 Jolla Cancer Res Found Method and composition for the treatment of thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5342830A (en) * 1990-11-16 1994-08-30 Cor Therapeutics, Inc. Antithrombosis agents
US5177188A (en) * 1990-12-03 1993-01-05 The Scripps Research Institute Methods and compositions for diagnosing chronic immune thrombocytopenic purpura
IE62682B1 (en) * 1990-12-03 1995-02-22 Scripps Research Inst Method and compositions for diagnosing chronic immune thrombocytopenic purpura
DK0578728T3 (en) * 1991-04-05 1999-04-12 Genentech Inc Platelet aggregation inhibitors, which have high specificity for GP IIbIIIa
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
CA2180140A1 (en) * 1993-12-27 1995-07-06 Jeffrey I. Weitz Methods and compositions for inhibiting thrombogenesis
US6808698B1 (en) 1999-03-26 2004-10-26 Bristol-Myers Squibb Pharma Company Method for localization of blood clots
US6254852B1 (en) 1999-07-16 2001-07-03 Dupont Pharmaceuticals Company Porous inorganic targeted ultrasound contrast agents
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
WO2003003988A2 (en) * 2001-07-06 2003-01-16 Oregon Health & Science University Peptides which modulate blood coagulation and methods of use thereof
GB0315754D0 (en) * 2003-07-04 2003-08-13 Univ Aberdeen Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4889919A (en) * 1986-08-13 1989-12-26 Zymogenetics, Inc. Biologically active PDGF derived A-chain homodimers
US4766073A (en) * 1985-02-25 1988-08-23 Zymogenetics Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4801542A (en) * 1984-10-12 1989-01-31 Zymogenetics, Inc. Expression of biologically active PDGF analogs in eucaryotic cells
US4789734A (en) * 1985-08-06 1988-12-06 La Jolla Cancer Research Foundation Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
DE3751632T2 (en) * 1986-08-13 1996-06-13 Zymogenetics Inc Expression of biologically active PDGF analogs in eukaryotic cells
ES2091749T3 (en) * 1987-04-22 1996-11-16 Chiron Corp PRODUCTION BY RECOMBINATION OF POLYPEPTIDES FROM THE A CHAIN OF THE PLATELET-DERIVED GROWTH FACTOR (FCDP).
EP0325224B1 (en) * 1988-01-22 1996-07-31 ZymoGenetics, Inc. Methods of producing secreted receptor analogs
US5149780A (en) * 1988-10-03 1992-09-22 The Scripps Research Institute Peptides and antibodies that inhibit integrin-ligand binding
WO1993007169A1 (en) * 1991-10-04 1993-04-15 Chiron Corporation Peptide inhibitors of platelet adhesion

Also Published As

Publication number Publication date
WO1990000178A1 (en) 1990-01-11
JP2892726B2 (en) 1999-05-17
EP0422125A1 (en) 1991-04-17
EP0422125A4 (en) 1992-07-08
ATE144535T1 (en) 1996-11-15
EP0422125B1 (en) 1996-10-23
JPH04503661A (en) 1992-07-02
DE68927379D1 (en) 1996-11-28
DE68927379T2 (en) 1997-02-20
US5705606A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
HK51197A (en) Platelet blocking peptides
DK1175909T3 (en) Therapeutic compositions of antibodies and antisense nucleic acids against Serrate
ATE380875T1 (en) CHIMERIC PROTEINS TO AVOID COMPLEMENT ACTIVATION
ATE368053T1 (en) ANTIMICROBIAL PEPTIDES
DK0728148T3 (en) Enhanced immunogenic compositions against human gastrin 17
ES2063113T3 (en) VIBORA POISON POLYPEPTIDES AND GENETIC EXPRESSION.
DE69715181D1 (en) PEPTIDE THE SOLUBLE FORM OF ACETYLCHOLINESTERASE WITH ACTIVITY AS A CALCIUM CHANNEL MODULATOR
ATE110742T1 (en) PEPTIDE COMPOUNDS.
ATE211765T1 (en) NEW FAMILY OF PROTEASE INHIBITORS AND OTHER BIOLOGICALLY ACTIVE SUBSTANCES
DE59108261D1 (en) HIV-gag protein peptides, their production and use
DK107389A (en) MODIFIED PROTEINS
EP0723016A3 (en) Activating factor of leukocytes
GR3005408T3 (en)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)